• 2-APB Workflows for ER Calcium Signaling

  2026-08-18

  2-APB enables rapid, pharmacological dissection of ER calcium release, calcium oscillations, SOCE, and downstream autophagy–apoptosis transitions. This guide translates a Bombyx mori starvation study into practical dosing, imaging, endpoint, and troubleshooting workflows while highlighting the compound’s important TRPC-related limitations.

• Amphotericin B: Ergosterol as an Assay Lever

  2026-08-17

  Explore how Amphotericin B converts fungal membrane sterol biology into a practical assay variable. This guide connects polyene mechanism, ergosterol-dependent synergy, immune signaling, and experimental design for more interpretable fungal infection research.

• PTEN mRNA: From Mechanism to Melanoma Translation

  2026-08-17

  PTEN restoration is moving from a genetic concept to a delivery-and-biology challenge. This thought-leadership guide examines how EZ Cap™ Human PTEN mRNA can support mechanistic cancer research, controlled mRNA transfection and expression, and translational studies inspired by emerging HA-LNP melanoma research.

• Podophyllotoxin: Reading Cell-Cycle Phenotypes

  2026-08-16

  Podophyllotoxin is a powerful cell cycle arrest agent for mechanistic cancer biology. This article presents an interpretation-first framework that separates microtubule disruption, apoptosis, and protective autophagy, using recent hepatocellular carcinoma research to improve assay decisions.

• 4–95, Nrf2, and Neuronal Ferroptosis in AD

  2026-08-15

  The reference study identifies compound 4–95 as a selective Keap1–Nrf2 protein–protein interaction inhibitor that protects neuronal models from ferroptosis and improves cognitive outcomes in an Aβ42-induced mouse model. Its main contribution is linking pharmacological Nrf2 activation to suppression of the Keap1–Nrf2–GPX4 axis, reduced amyloid and tau pathology, and functional behavioral rescue.

• Arctigenin at the Macrophage–Tumor Signaling Interface

  2026-08-14

  A translational framework for evaluating (-)-Arctigenin as a mechanistic probe of macrophage extracellular vesicle signaling, NF-κB activity, iNOS expression, and breast cancer progression—without confusing pathway convergence with clinical proof.

• 2-APB for ER Calcium Signaling Workflows

  2026-08-14

  Build reproducible calcium-release assays with 2-APB, a cell-permeable modulator suited to IP3R, SOCE, and TRPC investigations. This workflow connects calcium imaging with autophagy, calpain, apoptosis, and oxidative injury readouts while highlighting selectivity limits and practical troubleshooting.

• LY2603618: Chk1 Inhibitor Workflow Guide

  2026-08-13

  LY2603618 is a selective Chk1 inhibitor for dissecting checkpoint failure, DNA damage accumulation, and abnormal mitotic progression in cancer models. This workflow guide connects practical dose selection and troubleshooting with emerging nuclear cGAS–genome integrity research, while clearly separating validated findings from testable hypotheses.

• AMH–SMAD4 Signaling in PCOS Granulosa Cells

  2026-08-13

  A 2025 study links elevated anti-Müllerian hormone (AMH) with impaired granulosa-cell growth and apoptosis in a DHEA-induced rat model of polycystic ovary syndrome (PCOS), identifying SMAD4 as a functional mediator. Its combination of disease modeling, recombinant AMH treatment, and SMAD4 knockdown provides a mechanistic framework for interpreting follicular dysfunction in PCOS while also highlighting important limits of cell-based evidence.

• Angiotensin 1/2 (1-6): From Mechanism to Translation

  2026-08-12

  Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, offers translational researchers a defined probe for renin-angiotensin system research, vascular tone modulation, and cardiovascular and renal physiology. This thought-leadership article connects its classical biology with emerging evidence that short angiotensin fragments can influence SARS-CoV-2 spike–receptor binding, while distinguishing mechanistic opportunity from clinical proof.

• TCF25, Lysosomal Acidification, and Starvation Cell Death

  2026-08-11

  Ren et al. identify TCF25 as a nutrient-responsive regulator that increases V-ATPase-dependent lysosomal acidification during glucose starvation. The study shows that this response initially supports autophagy and ATP production but, during prolonged deprivation, drives ferritinophagy, lysosomal membrane permeabilization, and lysosome-dependent cell death, while TCF25 deficiency protects mice from hepatic ischemia-reperfusion injury.

• CD38 CAR Binder Structure and Affinity Tuning

  2026-08-11

  This 2026 iScience study combines crystallography, alanine scanning, enzymatic analysis, and CAR-T functional testing to explain how RP02 and 028 recognize CD38 through distinct epitope-engagement mechanisms. Its structure-guided tuning of 028 reduced CAR-T fratricide while preserving cytotoxicity against CD38-positive tumors, illustrating why affinity should be optimized together with epitope geometry and catalytic effects.

• Deferasirox Workflows for Iron-Lysosome Research

  2026-08-10

  Build a controlled Deferasirox workflow that separates iron depletion, oxidative stress, lysosomal remodeling, and cell death. The approach extends established iron-chelation experiments into nutrient-stress models while preserving the controls needed for credible translational interpretation.

• Anlotinib hydrochloride: Angiogenesis Workflow

  2026-08-09

  Build a mechanism-led angiogenesis workflow around Anlotinib hydrochloride, from endothelial migration and tube formation to receptor phosphorylation and ERK readouts. Its coordinated VEGFR2, PDGFRβ, and FGFR1 activity helps distinguish pathway blockade from nonspecific cytotoxicity in cancer research.

• Patient-Derived Organoids for Breast Adenomyoepithelioma

  2026-08-08

  A 2021 Bioengineered study established the first reported patient-derived organoid model from breast adenomyoepithelioma, preserving the tumor’s DNA signature and enabling comparative drug-response testing. The model provides a practical platform for studying this rare epithelial–myoepithelial tumor, although its single-patient origin and incomplete representation of the tumor microenvironment limit immediate generalization.

7634 records 5/509 page Previous Next 12345 下5页 Last page